| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 985 | 9.025 | 2.388 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 985 | 9.026 | 2.388 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 835 | 7.615 | 16.049 | 29 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | 150 | 1.410 | -13.661 | -29 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | 121 | 1.320 | -13.733 | -29 | 0 | 0 | 0 | 0 |
| Employees | - | - | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vetomed Adn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 237 | 29.510 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 1.128 | 7.965 | 5.582 | 5.241 | 5.124 | 5.140 | 5.125 | 5.096 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 985 | 7.951 | 5.233 | 4.548 | 4.447 | 5.140 | 5.125 | 5.096 |
| Cash | - | - | 143 | 14 | 349 | 692 | 677 | 0 | 0 | 0 |
| Shareholders Funds | - | - | 165 | 1.482 | -12.280 | -12.076 | -11.808 | -11.845 | -11.809 | -11.743 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.201 | 35.994 | 17.862 | 17.317 | 16.933 | 16.985 | 16.934 | 16.839 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Vetomed Adn Srl